2020
DOI: 10.1016/j.jinorgbio.2019.110885
|View full text |Cite
|
Sign up to set email alerts
|

Biological activity and photocatalytic properties of a naphthyl-imidazo phenanthroline (HNAIP) ligand and its [Ir(ppy)2(HNAIP)]Cl and [Rh(ppy)2(HNAIP)]Cl complexes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 11 publications
(2 citation statements)
references
References 53 publications
(59 reference statements)
0
2
0
Order By: Relevance
“…1,2 In recent decades, organometallic rhodium(III) complexes have received considerable interest in the scientific literature due to their particular biological properties. [3][4][5] Although the rhodium(III) center is regarded to be kinetically inert, the reactivity of rhodium(III) complexes toward biological targets is significantly increased by incorporating appropriate ligands, especially the negatively charged pentamethylcyclopentadienyl ligand (Cp*). 6,7 Recent interest has focused on the investigation of biological functions of promising organometallic rhodium(III) complexes in several biological models.…”
Section: Introductionmentioning
confidence: 99%
“…1,2 In recent decades, organometallic rhodium(III) complexes have received considerable interest in the scientific literature due to their particular biological properties. [3][4][5] Although the rhodium(III) center is regarded to be kinetically inert, the reactivity of rhodium(III) complexes toward biological targets is significantly increased by incorporating appropriate ligands, especially the negatively charged pentamethylcyclopentadienyl ligand (Cp*). 6,7 Recent interest has focused on the investigation of biological functions of promising organometallic rhodium(III) complexes in several biological models.…”
Section: Introductionmentioning
confidence: 99%
“…Iridium(III) complexes have been investigated for decades because of their stability (Jian et al, 2011;Lee et al, 2009;Tsuboyama et al, 2003), promising luminescent properties (Lin et al, 2011;Lowry et al, 2004;Tamayo et al, 2003) and medicinal applications, especially as anticancer agents (Hearn et al, 2018;Rubio et al, 2020;Xiao et al, 2018). The syntheses of cyclometallated iridium(III) complexes have mainly focused on the 2-phenylpyridine (ppy) ligand and its derivatives.…”
Section: Chemical Contextmentioning
confidence: 99%